Helius Medical Technologies, Inc. (HSDT) financial statements (2022 and earlier)

Company profile

Business Address 642 NEWTOWN YARDLEY ROAD
NEWTOWN, PA 18940
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
3/31/2016
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11,0053,3315,45925,5835,5622,644797
Cash and cash equivalents11,0053,3315,45925,5835,5622,644419
Short-term investments      378
Receivables2512305742757043999
Inventory, net of allowances, customer advances and progress billings476389598392   
Inventory476389598392   
Prepaid expense862735610447 502411
Other current assets   264 495 
Other undisclosed current assets    352  
Total current assets:12,5944,6857,24126,9616,6184,0411,216
Noncurrent Assets
Operating lease, right-of-use asset390552
Property, plant and equipment409486712554173  
Long-term investments and receivables   294   
Accounts and financing receivable, after allowance for credit loss   294   
Intangible assets, net (including goodwill)1,0961,2861,824    
Goodwill7637591,242    
Intangible assets, net (excluding goodwill)333527582    
Other noncurrent assets  181818  
Total noncurrent assets:1,5081,8623,106866191  
TOTAL ASSETS:14,1026,54710,34727,8276,8094,0411,216
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,5022,0843,1954,2044,7212,1811,198
Accounts payable1,0697471,6762,3923,479  
Accrued liabilities1,4331,3371,5191,8121,242  
Other undisclosed accounts payable and accrued liabilities     2,1811,198
Deferred revenue148281430
Debt  172    
Derivative instruments and hedges, liabilities  513,7699,578  
Other undisclosed current liabilities359   150 
Total current liabilities:2,6532,4243,80217,97314,2992,3311,198
Noncurrent Liabilities
Long-term debt and lease obligation 32465    
Operating lease, liability 32465
Liabilities, other than long-term debt193220245  1,7261,581
Deferred revenue193220245
Derivative instruments and hedges, liabilities     1,7261,581
Total noncurrent liabilities:193252710  1,7261,581
Total liabilities:2,8462,6764,51217,97314,2994,0572,779
Stockholders' equity
Stockholders' equity attributable to parent11,2563,8715,8359,854(7,490)(16)(1,563)
Common stock41312652,23024,34816,358
Common stock, value, subscriptions      40
Additional paid in capital149,412123,872111,479105,4116,6022,9412,435
Accumulated other comprehensive income (loss)(1,125)(1,099)(902)(591)47(999)(972)
Accumulated deficit(137,035)(118,903)(104,773)(94,992)(66,369)(26,305)(19,423)
Total stockholders' equity:11,2563,8715,8359,854(7,490)(16)(1,563)
TOTAL LIABILITIES AND EQUITY:14,1026,54710,34727,8276,8094,0411,216

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
3/31/2016
3/31/2015
Revenues522661500478   
Cost of revenue
(Cost of Goods and Services Sold)
(298)(388)(846)    
Other undisclosed gross profit  996    
Gross profit:224273650478   
Operating expenses(18,366)(14,659)(24,646)(27,153)(22,853)(9,317)(6,920)
Other undisclosed operating loss      (2,889)
Operating loss:(18,142)(14,386)(23,996)(26,675)(22,853)(9,317)(9,808)
Nonoperating income (expense)1025614,215(1,948)(5,171)2,436(30)
Foreign currency transaction gain (loss), before tax25  872(1,728)(19)866
Other nonoperating income 6395    
Interest and debt expense     268(176)
Loss from continuing operations before equity method investments, income taxes:(18,132)(14,130)(9,781)(28,623)(28,024)(6,613)(10,015)
Other undisclosed income from continuing operations before income taxes 28,26019,56257,24656,048  
Income (loss) before gain (loss) on sale of properties:(18,132)14,1309,78128,62328,024(6,613)(10,015)
Other undisclosed net loss (28,260)     
Net income (loss):(18,132)(14,130)9,78128,62328,024(6,613)(10,015)
Other undisclosed net income (loss) attributable to parent  (19,562)(57,246)(56,048)(268)176
Net loss available to common stockholders, diluted:(18,132)(14,130)(9,781)(28,623)(28,024)(6,882)(9,838)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
3/31/2016
3/31/2015
Net income (loss):(18,132)(14,130)9,78128,62328,024(6,613)(10,015)
Comprehensive income (loss):(18,132)(14,130)9,78128,62328,024(6,613)(10,015)
Other undisclosed comprehensive loss, net of tax, attributable to parent(26)(197)(19,873)(57,884)(54,273)(296)(795)
Comprehensive loss, net of tax, attributable to parent:(18,158)(14,327)(10,092)(29,261)(26,249)(6,910)(10,810)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: